| Report ID | 279813 |
| Drug Identification Number | 02415534 |
| Brand name | DUREZOL |
| Common or Proper name | DUREZOL .05% 5ML OPHTHALMIC EMULSION |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DIFLUPREDNATE |
| Strength(s) | 0.05% |
| Dosage form(s) | EMULSION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 1 bottle of 5 mL |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2026-03-10 |
| Actual start date | |
| Estimated end date | 2026-05-29 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-03-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-05 | French | Compare |
| v1 | 2026-03-05 | English | Compare |
Showing 1 to 2 of 2